Nob Hill Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Nob Hill Therapeutics's estimated annual revenue is currently $930k per year.
- Nob Hill Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Nob Hill Therapeutics has 6 Employees.
- Nob Hill Therapeutics grew their employee count by -14% last year.
Nob Hill Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | VP, Research & Development | Reveal Email/Phone |
4 | Executive Chairman | Reveal Email/Phone |
Nob Hill Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 35 | 6% | N/A | N/A |
#2 | $1.8M | 23 | 53% | $12.8M | N/A |
#3 | $2.8M | 18 | -18% | N/A | N/A |
#4 | $2.3M | 15 | 0% | N/A | N/A |
#5 | $6.4M | 41 | 5% | N/A | N/A |
#6 | $2.5M | 16 | 33% | N/A | N/A |
#7 | $2.5M | 16 | 0% | $4.25M | N/A |
#8 | $22.5M | 145 | 9% | N/A | N/A |
#9 | $3.7M | 24 | -8% | $46.4M | N/A |
#10 | $1.4M | 9 | 0% | N/A | N/A |
What Is Nob Hill Therapeutics?
Nob Hill Therapeutics mission is to commercialize the first-of-its-kind dry powder nebulizer (DryNebTM ) inhalation drug delivery platform. NHT is focused on creating effective inhalation therapies to address lower respiratory tract infections (the 5th leading overall cause of death worldwide) and other deadly lung diseases.
keywords:N/AN/A
Total Funding
6
Number of Employees
$930k
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 6 | -14% | N/A |
#2 | $0.4M | 6 | 0% | N/A |
#3 | $0.4M | 6 | 20% | N/A |
#4 | $0.8M | 6 | 0% | N/A |
#5 | $0.7M | 7 | N/A | N/A |